Actavis expands renewable energy powered pharma manufacturing plant
Actavis has expanded its renewable energy powered pharmaceutical manufacturing site in Iceland for tablet manufacturing and packaging.
Archives for January 19, 2011
Clinipace expects continued success in 2011
Clinipace Worldwide claims it has closed its best year to date by doubling its revenues in 2010 and gaining 16 projects awarded by 12 new clients.
Deltex ordered to permanently halt manufacturing ops
US CMO Deltex Pharmaceuticals has been ordered to permanently halt manufacturing operations and recall all drugs it has distributed since October 2008, under a consent decree obtained by the FDA.
Green plant-based production to boost Brazilian biologics
Bio-Manguinhos has licensed green plant-based vaccine production technology to position Brazil at the forefront of biologics manufacture.
A new job for former EMA chief and Catalent strengthening its production team – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new job for former EMA chief and Catalent strengthening its production team.
Famar plans to acquire Sanofi site for sterile dose expansion
Famar plans to acquire a Sanofi-aventis site in Madrid, Spain to further expand its sterile dose capacity and capabilities.
Cambrex’s India site receives EU GMP certification
Cambrex’s Hyderabad, India plant has received a GMP compliance certificate, accepted throughout the EU, from the DKMA.
CIT joins “ScreenTox” stem cell development project
French contract research organisation (CRO) CIT will work on in vitro toxicity testing for pharmaceutical and cosmetic ingredients as the newest member of the European “ScreenTox” network.